0.00
0.00%
Close of 5 Nov 2026, in USD
About Electromedical Technologies
From its filings with the US Securities and Exchange Commission
Electromedical Technologies is based in Scottsdale, Arizona and is incorporated in Delaware. Its shares trade on OTC under the ticker EMED. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2023, it reported revenue of $1.3m and a net loss of $2.6m. At that date it held total assets of $748,383 and shareholders' equity of −$2.9m.
The Company was formed in Nevada in August 30, 2002 as IntelSource Group, Inc. and began operations in 2003. In 2007, IntelSource Group, Inc. merged with ElectroMedical Technologies, LLC. The Company began acting as Electro Medical Technologies, LLC, an Arizona limited liability company on November 9, 2010, after the merger with ElectroMedical Technologies, LLC, a Nevada Company. The Company converted to a corporation in the State of Delaware on August 23, 2017.
Electromedical Technologies is a bioelectronics manufacturing and marketing company. We offer U.S. Food and Drug Administration (FDA) cleared medical devices for pain management.
Bioelectronics is a developing field of “electronic” medicine that uses electrical impulses over the body’s neural circuitry to try to alleviate pain without drugs. The human body is controlled by electrical signals sent through the nervous system, which can become distorted after accidents or because of disease. The field of bioelectronic medicine aims to safely correct irregularities in the nervous system by modifying the electrical language of the body related to pain relief.
Quoted from its 10-K, filed 1 May 2024. Read the filing on SEC.gov ↗
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 17 Jun 2019
- Employees
- 8
- Website
- electromedtech.com ↗
- Head office
- 16561 N 92ND STREET, SCOTTSDALE, AZ, 85260
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Leadership
Pay as last reported
- Mr. Matthew WolfsonPresident, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary$864,000
- Mr. Petar GajicEmployee Director$5,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- WellnessPro Plus is an intelligent bioelectronics therapy device for pain management used by consumers and professionals.
- WellnessPro POD and Wellness ION Pen offer targeted frequency stimulation and expanded wavelengths for pain relief.
- Electromedical Technologies Inc. develops electronic medicine using electrical impulses through neural circuitry without drugs.
Weaknesses
- Electromedical Technologies Inc. has only 8 full-time employees in Scottsdale, Arizona.
- The company went public on 17 June 2019 with limited workforce size.
- Wellness ION Pen is intended for over-the-counter sale but lacks market penetration.
Opportunities
- The US market offers significant growth potential for bioelectronics pain management devices.
- Developing electronic medicine using neural circuitry could expand into new medical applications.
- WellnessPro Plus generates micro-current stimulation mimicking the body's natural signals for enhanced therapy.
Threats
- The US healthcare sector faces regulatory challenges for new medical devices.
- Competition in the pain management market may increase with more electronic medicine solutions.
- Electromedical Technologies Inc. must navigate FDA approval processes for over-the-counter devices.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.